Effects of extracts of lupine seed on blood glucose levels in glucose resistant mice: antihyperglycemic effects of Lupinus albus (white lupine, Egypt) and Lupinus caudatus (tailcup lupine, Mesa Verde National Park)

J Herb Pharmacother. 2006;6(3-4):89-104. doi: 10.1080/j157v06n03_04.

Abstract

Lupine is a medicinal food plant with potential value in the management of diabetes. In white mice, extracts of seeds of the white lupine [Lupinus albus (L. termis L.)] were associated with increased tolerance to an oral glucose bolus. Antihyperglycemic activity was present in extracts of the whole seed but not extracts of the seed coat, and was not detected when glucose was administered intraperitoneally rather than orally. However, in contrast to results seen with the prescription drug, acarbose, lupine extract did not appear to increase the bulk or carbohydrate content of the feces. Antihyperglycemic activity was also seen in extracts of the tailcup lupine (L. caudatus) found in the Four Corners Region of the United States.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Feces / chemistry
  • Hypolipidemic Agents / pharmacology*
  • Lupinus
  • Mice
  • Oligopeptides / pharmacology*
  • Phytotherapy*
  • Plant Extracts / pharmacology*

Substances

  • Blood Glucose
  • Hypolipidemic Agents
  • Lupinus albus extract 105
  • Oligopeptides
  • Plant Extracts